Sangamo Signs $20 Million Gene Therapy Deal with Astellas; Shares Surge
Daily NewsRICHMOND, California - Sangamo Therapeutics, Inc. (NASDAQ:SGMO) announced that it has entered into a licensing agreement with Astellas Pharma Inc. (TSE:4503), lea...
Read More